ArticleClinical drug investigation2016

Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel Dipeptidyl Peptidase-4 Inhibitor with Insulin Sensitizing Properties.

Eiji Kutoh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.